Tennis Icon Chris Evert Battles Ovarian Cancer Again

Tennis icon Chris Evert is navigating her third battle with ovarian cancer, having announced her recurrence in June 2026. This latest challenge comes after initial diagnoses and treatments for the disease. Her personal health journey significantly intersects with her family history, particularly the loss of her sister Jeanne to ovarian cancer.

Jeanne's passing in February 2020 prompted genetic testing that revealed a BRCA-related risk. This led to Evert's own positive test result, which in turn facilitated the early discovery of her Stage 1C ovarian cancer in December 2021 following a preventive hysterectomy.

Evert publicly shared her diagnosis in January 2022, aiming to highlight the importance of understanding family medical history and genetic predispositions. Despite completing chemotherapy and previously being in remission, the cancer returned, necessitating further treatment and causing her to miss Wimbledon in 2026.

Her resilience and openness about this ongoing health crisis extend her legacy beyond her 18 Grand Slam singles titles. Evert's willingness to share her experience serves as a powerful testament to the importance of proactive health awareness and medical consultation, particularly concerning inherited cancer risks.